Why the study?
Does pretreatment with total Glycosides of Ranunculus Japonius prevent hypertrophy in neonatal rat cardiomyocytes exposed to isoproterenol or angiotensin 2?
Does pretreatment with total Glycosides of Ranunculus Japonius prevent hypertrophy in neonatal rat cardiomyocytes exposed to isoproterenol or angiotensin 2?
Answers are grounded in this paper and cite their sources.
In vitro, total Glycosides of Ranunculus Japonius prevent cardiomyocyte hypertrophy induced by isoproterenol or angiotensin 2, likely by normalizing SERCA2a expression and activity.
OBJECTIVE: To evaluate the in vitro anti-hypertrophic effect of total Glycosides of Ranunculus Japonius (TGRJ). METHODS: Neonatal rat cardiomyocytes were cultured and hypertrophy was induced by administrating isoproterenol (ISO, 10 µmol/L) or angiotensin 2 (Ang 2, 1 µmol/L) for 48 hours. In the treatment groups, cells were pretreated with TGRJ (0.3 g/L) for 30 minutes prior to hypertrophic stimuli. The anti-hypertrophic effects of TGRJ were examined by measuring cell size, total protein content, and protein synthesis. Intracellular free Ca(2+) concentration ([Ca(2+)]i) was evaluated using fluorescence dye Fura-2/AM. Sacroplasmic/endoplasmic reticulum Ca(2+) ATPase 2a (SERCA2a), atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and beta-myosin heavy chain (β-MHC) protein expression levels were measured by Western blotting . SERCA2a activity was assayed by p-nitrophenal phosphate disodium salt hexahydrate method. RESULTS: Increased cell size, total protein content, and protein synthesis following ISO or Ang 2 stimulation were significantly inhibited by pretreatment with TGRJ (all P<0.05). This anti-hypertrophic effect of TGRJ was confirmed by its suppressing effect on elevated expression of the three hypertrophic related genetic markers, ANP, BNP, and β-MHC. In addition, TGRJ inhibited ISO or Ang 2 induced up-regulation of [Ca(2+)]i under chronic but not acute conditions. And ISO or Ang 2 induced down-regulation of SERCA2a expression and activity was also effectively rectified by TGRJ pretreatment. CONCLUSIONS: The results of present study suggested that TGRJ could prevent ISO or Ang 2 induced cardiac hypertrophy through improving chronic [Ca(2+)]i disorder, might via normalizing SERCA2a expression and activity.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: